Intec Systems

Intec Systems pioneered the commercial development of the first Implantable Cardiac Defibrillator (ICD) for treatment of recurrent/sustained ventricular tachycardia or fibrillation. Working alongside Dr. Michael Mirowski's team at Sinai Hospital in Baltimore, the first ICD was implanted in humans in 1980. The device was subsequently granted FDA approval and Intec Systems was acquired in 1985 for $150 million by Eli Lilley.

To date, more than 200,000 patients have been fitted with ICD’s, and the market has grown to over $1 billion annually. Intec's investors realized, on average, over 5 times their investment. The company's early investors realized up to 10 times their capital.